Filing Details
- Accession Number:
- 0001140361-25-006272
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-02-27 16:01:15
- Reporting Period:
- 2024-05-17
- Filing Date:
- 2025-02-27
- Accepted Time:
- 2025-02-27 16:01:15
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1281895 | Rocket Pharmaceuticals Inc. | RCKT | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1726398 | David Jonathan Schwartz | C/O Rocket Pharmaceuticals, Inc. 9 Cedarbrook Drive Cranbury NJ 08512 | See Remarks | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2024-05-17 | 2,754 | $23.35 | 169,659 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-08-16 | 2,710 | $18.50 | 166,949 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-11-21 | 3,097 | $13.05 | 163,852 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-02-25 | 6,532 | $10.58 | 237,638 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- Holdings include Restricted Stock Units ("RSUs") that convert to common stock on a one-for-one basis.
- The shares of common stock were sold by the Reporting Person in order to pay tax withholding obligations in connection with the vesting of RSUs.
- Inclusive of the acquisition of 80,318 RSUs that convert to common stock on a one-for-one basis, as reported on the Reporting Person's Form 4 filed on 02/13/2025.
Billionaire Hedge Funds
